nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP3A5—prostate cancer	0.0952	0.287	CbGaD
Fluvoxamine—CYP2E1—prostate cancer	0.0655	0.198	CbGaD
Fluvoxamine—CYP2C19—prostate cancer	0.0648	0.196	CbGaD
Fluvoxamine—CYP1A1—prostate cancer	0.0646	0.195	CbGaD
Fluvoxamine—CYP3A4—prostate cancer	0.0412	0.124	CbGaD
Fluvoxamine—CYP1A1—Flutamide—prostate cancer	0.0225	0.0551	CbGbCtD
Fluvoxamine—CYP1A1—Estrone—prostate cancer	0.0163	0.0398	CbGbCtD
Fluvoxamine—CYP3A5—Flutamide—prostate cancer	0.0135	0.0331	CbGbCtD
Fluvoxamine—CYP2C19—Bicalutamide—prostate cancer	0.0132	0.0322	CbGbCtD
Fluvoxamine—CYP2C19—Nilutamide—prostate cancer	0.0132	0.0322	CbGbCtD
Fluvoxamine—CYP2E1—Estrone—prostate cancer	0.0126	0.0308	CbGbCtD
Fluvoxamine—CYP2B6—Estrone—prostate cancer	0.0124	0.0303	CbGbCtD
Fluvoxamine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0121	0.0296	CbGbCtD
Fluvoxamine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0111	0.027	CbGbCtD
Fluvoxamine—CYP2C9—Bicalutamide—prostate cancer	0.0109	0.0268	CbGbCtD
Fluvoxamine—CYP2C9—Nilutamide—prostate cancer	0.0109	0.0268	CbGbCtD
Fluvoxamine—CYP2C19—Flutamide—prostate cancer	0.0109	0.0267	CbGbCtD
Fluvoxamine—CYP1A2—Flutamide—prostate cancer	0.0101	0.0246	CbGbCtD
Fluvoxamine—CYP2D6—Bicalutamide—prostate cancer	0.01	0.0245	CbGbCtD
Fluvoxamine—CYP3A5—Cabazitaxel—prostate cancer	0.01	0.0245	CbGbCtD
Fluvoxamine—ABCB1—Estramustine—prostate cancer	0.00988	0.0241	CbGbCtD
Fluvoxamine—CYP3A5—Estrone—prostate cancer	0.00978	0.0239	CbGbCtD
Fluvoxamine—CYP1A1—Estradiol—prostate cancer	0.00936	0.0229	CbGbCtD
Fluvoxamine—CYP2D6—Abiraterone—prostate cancer	0.0083	0.0203	CbGbCtD
Fluvoxamine—CYP3A7—Estradiol—prostate cancer	0.00749	0.0183	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00749	0.0183	CbGbCtD
Fluvoxamine—CYP2E1—Mitoxantrone—prostate cancer	0.00749	0.0183	CbGbCtD
Fluvoxamine—CYP1A2—Estrone—prostate cancer	0.00728	0.0178	CbGbCtD
Fluvoxamine—CYP2C9—Estrone—prostate cancer	0.00656	0.016	CbGbCtD
Fluvoxamine—ABCB1—Cabazitaxel—prostate cancer	0.00651	0.0159	CbGbCtD
Fluvoxamine—CYP3A4—Bicalutamide—prostate cancer	0.00637	0.0156	CbGbCtD
Fluvoxamine—ABCB1—Estrone—prostate cancer	0.00637	0.0156	CbGbCtD
Fluvoxamine—CYP3A4—Estramustine—prostate cancer	0.00592	0.0145	CbGbCtD
Fluvoxamine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00567	0.0139	CbGbCtD
Fluvoxamine—CYP3A5—Estradiol—prostate cancer	0.00562	0.0137	CbGbCtD
Fluvoxamine—CYP3A4—Flutamide—prostate cancer	0.00528	0.0129	CbGbCtD
Fluvoxamine—CYP3A4—Abiraterone—prostate cancer	0.00528	0.0129	CbGbCtD
Fluvoxamine—CYP2C9—Capecitabine—prostate cancer	0.00497	0.0121	CbGbCtD
Fluvoxamine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00476	0.0116	CbGbCtD
Fluvoxamine—CYP2E1—Etoposide—prostate cancer	0.00472	0.0115	CbGbCtD
Fluvoxamine—CYP2C19—Estradiol—prostate cancer	0.00453	0.0111	CbGbCtD
Fluvoxamine—CYP3A7—Docetaxel—prostate cancer	0.00447	0.0109	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00447	0.0109	CbGbCtD
Fluvoxamine—CYP1A2—Estradiol—prostate cancer	0.00418	0.0102	CbGbCtD
Fluvoxamine—ABCB1—Conjugated Estrogens—prostate cancer	0.00416	0.0102	CbGbCtD
Fluvoxamine—Ridogrel—TBXAS1—prostate cancer	0.00401	1	CrCbGaD
Fluvoxamine—CYP3A4—Cabazitaxel—prostate cancer	0.0039	0.00953	CbGbCtD
Fluvoxamine—CYP2C19—Prednisone—prostate cancer	0.0039	0.00952	CbGbCtD
Fluvoxamine—CYP3A4—Estrone—prostate cancer	0.00381	0.00932	CbGbCtD
Fluvoxamine—ABCB1—Mitoxantrone—prostate cancer	0.00379	0.00925	CbGbCtD
Fluvoxamine—CYP2C9—Estradiol—prostate cancer	0.00377	0.00921	CbGbCtD
Fluvoxamine—CYP3A5—Etoposide—prostate cancer	0.00367	0.00896	CbGbCtD
Fluvoxamine—ABCB1—Estradiol—prostate cancer	0.00366	0.00893	CbGbCtD
Fluvoxamine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0034	0.00831	CbGbCtD
Fluvoxamine—CYP3A5—Docetaxel—prostate cancer	0.00336	0.0082	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—prostate cancer	0.00318	0.00776	CbGbCtD
Fluvoxamine—ABCB1—Prednisone—prostate cancer	0.00314	0.00768	CbGbCtD
Fluvoxamine—CYP1A2—Etoposide—prostate cancer	0.00273	0.00667	CbGbCtD
Fluvoxamine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0025	0.0061	CbGbCtD
Fluvoxamine—ABCB1—Etoposide—prostate cancer	0.00239	0.00583	CbGbCtD
Fluvoxamine—CYP3A4—Mitoxantrone—prostate cancer	0.00227	0.00554	CbGbCtD
Fluvoxamine—CYP3A4—Estradiol—prostate cancer	0.00219	0.00535	CbGbCtD
Fluvoxamine—ABCB1—Docetaxel—prostate cancer	0.00218	0.00534	CbGbCtD
Fluvoxamine—CYP3A4—Prednisone—prostate cancer	0.00188	0.0046	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—prostate cancer	0.00163	0.00398	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—prostate cancer	0.00153	0.00375	CbGbCtD
Fluvoxamine—CYP3A4—Etoposide—prostate cancer	0.00143	0.00349	CbGbCtD
Fluvoxamine—CYP2C19—urine—prostate cancer	0.0014	0.0985	CbGeAlD
Fluvoxamine—CYP3A4—Docetaxel—prostate cancer	0.00131	0.0032	CbGbCtD
Fluvoxamine—CYP1A2—urine—prostate cancer	0.00115	0.0805	CbGeAlD
Fluvoxamine—CYP2C9—urine—prostate cancer	0.00109	0.0764	CbGeAlD
Fluvoxamine—CYP2E1—urine—prostate cancer	0.00103	0.0724	CbGeAlD
Fluvoxamine—CYP3A4—Doxorubicin—prostate cancer	0.000976	0.00238	CbGbCtD
Fluvoxamine—CYP3A4—urine—prostate cancer	0.000829	0.0583	CbGeAlD
Fluvoxamine—CYP2D6—urine—prostate cancer	0.000816	0.0573	CbGeAlD
Fluvoxamine—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000803	1	CbGdCrCtD
Fluvoxamine—SIGMAR1—prostate gland—prostate cancer	0.000604	0.0424	CbGeAlD
Fluvoxamine—SIGMAR1—seminal vesicle—prostate cancer	0.000511	0.0359	CbGeAlD
Fluvoxamine—SIGMAR1—urethra—prostate cancer	0.000404	0.0284	CbGeAlD
Fluvoxamine—CYP3A5—prostate gland—prostate cancer	0.000397	0.0279	CbGeAlD
Fluvoxamine—CYP2E1—prostate gland—prostate cancer	0.00037	0.026	CbGeAlD
Fluvoxamine—CYP2E1—seminal vesicle—prostate cancer	0.000313	0.022	CbGeAlD
Fluvoxamine—SIGMAR1—bone marrow—prostate cancer	0.000311	0.0219	CbGeAlD
Fluvoxamine—CYP1A1—epithelium—prostate cancer	0.000298	0.0209	CbGeAlD
Fluvoxamine—SLC6A3—testis—prostate cancer	0.000292	0.0205	CbGeAlD
Fluvoxamine—CYP1A2—renal system—prostate cancer	0.00028	0.0197	CbGeAlD
Fluvoxamine—CYP1A1—renal system—prostate cancer	0.000277	0.0194	CbGeAlD
Fluvoxamine—CYP1A1—urethra—prostate cancer	0.000272	0.0191	CbGeAlD
Fluvoxamine—CYP3A5—renal system—prostate cancer	0.00027	0.019	CbGeAlD
Fluvoxamine—CYP2B6—renal system—prostate cancer	0.000269	0.0189	CbGeAlD
Fluvoxamine—SIGMAR1—testis—prostate cancer	0.000266	0.0187	CbGeAlD
Fluvoxamine—CYP2E1—renal system—prostate cancer	0.000252	0.0177	CbGeAlD
Fluvoxamine—CYP2E1—urethra—prostate cancer	0.000248	0.0174	CbGeAlD
Fluvoxamine—ABCB1—prostate gland—prostate cancer	0.000211	0.0148	CbGeAlD
Fluvoxamine—CYP3A4—renal system—prostate cancer	0.000203	0.0143	CbGeAlD
Fluvoxamine—CYP2D6—renal system—prostate cancer	0.0002	0.014	CbGeAlD
Fluvoxamine—SIGMAR1—lymph node—prostate cancer	0.000193	0.0135	CbGeAlD
Fluvoxamine—ABCB1—seminal vesicle—prostate cancer	0.000178	0.0125	CbGeAlD
Fluvoxamine—CYP2B6—testis—prostate cancer	0.000174	0.0122	CbGeAlD
Fluvoxamine—CYP2E1—testis—prostate cancer	0.000163	0.0115	CbGeAlD
Fluvoxamine—ABCB1—epithelium—prostate cancer	0.000155	0.0109	CbGeAlD
Fluvoxamine—ABCB1—renal system—prostate cancer	0.000144	0.0101	CbGeAlD
Fluvoxamine—ABCB1—urethra—prostate cancer	0.000141	0.00991	CbGeAlD
Fluvoxamine—CYP1A1—lymph node—prostate cancer	0.00013	0.0091	CbGeAlD
Fluvoxamine—CYP2D6—testis—prostate cancer	0.000129	0.00907	CbGeAlD
Fluvoxamine—ABCB1—bone marrow—prostate cancer	0.000109	0.00763	CbGeAlD
Fluvoxamine—ABCB1—testis—prostate cancer	9.28e-05	0.00652	CbGeAlD
Fluvoxamine—ABCB1—lymph node—prostate cancer	6.73e-05	0.00473	CbGeAlD
Fluvoxamine—Hypotension—Capecitabine—prostate cancer	1.71e-05	0.000113	CcSEcCtD
Fluvoxamine—Insomnia—Docetaxel—prostate cancer	1.71e-05	0.000113	CcSEcCtD
Fluvoxamine—Arthralgia—Prednisone—prostate cancer	1.7e-05	0.000112	CcSEcCtD
Fluvoxamine—Myalgia—Prednisone—prostate cancer	1.7e-05	0.000112	CcSEcCtD
Fluvoxamine—Paraesthesia—Docetaxel—prostate cancer	1.7e-05	0.000112	CcSEcCtD
Fluvoxamine—Erythema multiforme—Epirubicin—prostate cancer	1.7e-05	0.000112	CcSEcCtD
Fluvoxamine—Anxiety—Prednisone—prostate cancer	1.7e-05	0.000112	CcSEcCtD
Fluvoxamine—Bradycardia—Doxorubicin—prostate cancer	1.69e-05	0.000111	CcSEcCtD
Fluvoxamine—Dyspnoea—Docetaxel—prostate cancer	1.69e-05	0.000111	CcSEcCtD
Fluvoxamine—Somnolence—Docetaxel—prostate cancer	1.68e-05	0.000111	CcSEcCtD
Fluvoxamine—Discomfort—Prednisone—prostate cancer	1.68e-05	0.000111	CcSEcCtD
Fluvoxamine—Eye disorder—Epirubicin—prostate cancer	1.68e-05	0.000111	CcSEcCtD
Fluvoxamine—Hypersensitivity—Etoposide—prostate cancer	1.68e-05	0.00011	CcSEcCtD
Fluvoxamine—Tinnitus—Epirubicin—prostate cancer	1.67e-05	0.00011	CcSEcCtD
Fluvoxamine—Haemoglobin—Doxorubicin—prostate cancer	1.67e-05	0.00011	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.67e-05	0.00011	CcSEcCtD
Fluvoxamine—Cardiac disorder—Epirubicin—prostate cancer	1.67e-05	0.00011	CcSEcCtD
Fluvoxamine—Rhinitis—Doxorubicin—prostate cancer	1.67e-05	0.00011	CcSEcCtD
Fluvoxamine—Dyspepsia—Docetaxel—prostate cancer	1.66e-05	0.00011	CcSEcCtD
Fluvoxamine—Hepatitis—Doxorubicin—prostate cancer	1.66e-05	0.000109	CcSEcCtD
Fluvoxamine—Haemorrhage—Doxorubicin—prostate cancer	1.66e-05	0.000109	CcSEcCtD
Fluvoxamine—Insomnia—Capecitabine—prostate cancer	1.66e-05	0.000109	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Doxorubicin—prostate cancer	1.65e-05	0.000109	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—prostate cancer	1.65e-05	0.000109	CcSEcCtD
Fluvoxamine—Paraesthesia—Capecitabine—prostate cancer	1.64e-05	0.000108	CcSEcCtD
Fluvoxamine—Decreased appetite—Docetaxel—prostate cancer	1.64e-05	0.000108	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—prostate cancer	1.64e-05	0.000108	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—prostate cancer	1.64e-05	0.000108	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Docetaxel—prostate cancer	1.63e-05	0.000108	CcSEcCtD
Fluvoxamine—Asthenia—Etoposide—prostate cancer	1.63e-05	0.000108	CcSEcCtD
Fluvoxamine—Dyspnoea—Capecitabine—prostate cancer	1.63e-05	0.000108	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Prednisone—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Fluvoxamine—Oedema—Prednisone—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Fluvoxamine—Fatigue—Docetaxel—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Fluvoxamine—Angiopathy—Epirubicin—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Fluvoxamine—Nausea—Mitoxantrone—prostate cancer	1.63e-05	0.000107	CcSEcCtD
Fluvoxamine—Infection—Prednisone—prostate cancer	1.62e-05	0.000107	CcSEcCtD
Fluvoxamine—Constipation—Docetaxel—prostate cancer	1.62e-05	0.000107	CcSEcCtD
Fluvoxamine—Pain—Docetaxel—prostate cancer	1.62e-05	0.000107	CcSEcCtD
Fluvoxamine—Dyspepsia—Capecitabine—prostate cancer	1.61e-05	0.000106	CcSEcCtD
Fluvoxamine—Chills—Epirubicin—prostate cancer	1.61e-05	0.000106	CcSEcCtD
Fluvoxamine—Pruritus—Etoposide—prostate cancer	1.61e-05	0.000106	CcSEcCtD
Fluvoxamine—Shock—Prednisone—prostate cancer	1.6e-05	0.000106	CcSEcCtD
Fluvoxamine—Arrhythmia—Epirubicin—prostate cancer	1.6e-05	0.000106	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—prostate cancer	1.6e-05	0.000105	CcSEcCtD
Fluvoxamine—Nervous system disorder—Prednisone—prostate cancer	1.6e-05	0.000105	CcSEcCtD
Fluvoxamine—Tachycardia—Prednisone—prostate cancer	1.59e-05	0.000105	CcSEcCtD
Fluvoxamine—Decreased appetite—Capecitabine—prostate cancer	1.59e-05	0.000105	CcSEcCtD
Fluvoxamine—Alopecia—Epirubicin—prostate cancer	1.59e-05	0.000105	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Capecitabine—prostate cancer	1.58e-05	0.000104	CcSEcCtD
Fluvoxamine—Fatigue—Capecitabine—prostate cancer	1.58e-05	0.000104	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Prednisone—prostate cancer	1.58e-05	0.000104	CcSEcCtD
Fluvoxamine—Mental disorder—Epirubicin—prostate cancer	1.57e-05	0.000104	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—prostate cancer	1.57e-05	0.000103	CcSEcCtD
Fluvoxamine—Pain—Capecitabine—prostate cancer	1.57e-05	0.000103	CcSEcCtD
Fluvoxamine—Constipation—Capecitabine—prostate cancer	1.57e-05	0.000103	CcSEcCtD
Fluvoxamine—Malnutrition—Epirubicin—prostate cancer	1.56e-05	0.000103	CcSEcCtD
Fluvoxamine—Feeling abnormal—Docetaxel—prostate cancer	1.56e-05	0.000103	CcSEcCtD
Fluvoxamine—Diarrhoea—Etoposide—prostate cancer	1.56e-05	0.000103	CcSEcCtD
Fluvoxamine—Anorexia—Prednisone—prostate cancer	1.55e-05	0.000102	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—prostate cancer	1.55e-05	0.000102	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—prostate cancer	1.55e-05	0.000102	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Docetaxel—prostate cancer	1.55e-05	0.000102	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—prostate cancer	1.54e-05	0.000102	CcSEcCtD
Fluvoxamine—Flatulence—Epirubicin—prostate cancer	1.54e-05	0.000101	CcSEcCtD
Fluvoxamine—Tension—Epirubicin—prostate cancer	1.53e-05	0.000101	CcSEcCtD
Fluvoxamine—Dysgeusia—Epirubicin—prostate cancer	1.53e-05	0.000101	CcSEcCtD
Fluvoxamine—Nervousness—Epirubicin—prostate cancer	1.52e-05	0.0001	CcSEcCtD
Fluvoxamine—Back pain—Epirubicin—prostate cancer	1.51e-05	9.96e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Capecitabine—prostate cancer	1.51e-05	9.94e-05	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—prostate cancer	1.51e-05	9.93e-05	CcSEcCtD
Fluvoxamine—Dizziness—Etoposide—prostate cancer	1.51e-05	9.91e-05	CcSEcCtD
Fluvoxamine—Muscle spasms—Epirubicin—prostate cancer	1.5e-05	9.9e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Capecitabine—prostate cancer	1.5e-05	9.86e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Docetaxel—prostate cancer	1.5e-05	9.85e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Docetaxel—prostate cancer	1.5e-05	9.85e-05	CcSEcCtD
Fluvoxamine—Chills—Doxorubicin—prostate cancer	1.49e-05	9.82e-05	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Prednisone—prostate cancer	1.49e-05	9.79e-05	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—prostate cancer	1.48e-05	9.78e-05	CcSEcCtD
Fluvoxamine—Insomnia—Prednisone—prostate cancer	1.48e-05	9.72e-05	CcSEcCtD
Fluvoxamine—Vision blurred—Epirubicin—prostate cancer	1.47e-05	9.7e-05	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—prostate cancer	1.47e-05	9.67e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Prednisone—prostate cancer	1.46e-05	9.65e-05	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—prostate cancer	1.46e-05	9.59e-05	CcSEcCtD
Fluvoxamine—Urticaria—Capecitabine—prostate cancer	1.45e-05	9.58e-05	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Epirubicin—prostate cancer	1.45e-05	9.55e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Capecitabine—prostate cancer	1.45e-05	9.54e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Capecitabine—prostate cancer	1.45e-05	9.54e-05	CcSEcCtD
Fluvoxamine—Vomiting—Etoposide—prostate cancer	1.45e-05	9.53e-05	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—prostate cancer	1.45e-05	9.53e-05	CcSEcCtD
Fluvoxamine—Anaemia—Epirubicin—prostate cancer	1.44e-05	9.52e-05	CcSEcCtD
Fluvoxamine—Agitation—Epirubicin—prostate cancer	1.44e-05	9.46e-05	CcSEcCtD
Fluvoxamine—Dyspepsia—Prednisone—prostate cancer	1.44e-05	9.46e-05	CcSEcCtD
Fluvoxamine—Rash—Etoposide—prostate cancer	1.44e-05	9.45e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Etoposide—prostate cancer	1.43e-05	9.44e-05	CcSEcCtD
Fluvoxamine—Headache—Etoposide—prostate cancer	1.43e-05	9.39e-05	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—prostate cancer	1.43e-05	9.39e-05	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—prostate cancer	1.42e-05	9.35e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Prednisone—prostate cancer	1.42e-05	9.34e-05	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—prostate cancer	1.42e-05	9.33e-05	CcSEcCtD
Fluvoxamine—Malaise—Epirubicin—prostate cancer	1.41e-05	9.28e-05	CcSEcCtD
Fluvoxamine—Fatigue—Prednisone—prostate cancer	1.41e-05	9.26e-05	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—prostate cancer	1.4e-05	9.25e-05	CcSEcCtD
Fluvoxamine—Vertigo—Epirubicin—prostate cancer	1.4e-05	9.25e-05	CcSEcCtD
Fluvoxamine—Syncope—Epirubicin—prostate cancer	1.4e-05	9.23e-05	CcSEcCtD
Fluvoxamine—Leukopenia—Epirubicin—prostate cancer	1.4e-05	9.22e-05	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—prostate cancer	1.4e-05	9.22e-05	CcSEcCtD
Fluvoxamine—Constipation—Prednisone—prostate cancer	1.39e-05	9.19e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Docetaxel—prostate cancer	1.39e-05	9.18e-05	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—prostate cancer	1.39e-05	9.16e-05	CcSEcCtD
Fluvoxamine—Palpitations—Epirubicin—prostate cancer	1.38e-05	9.1e-05	CcSEcCtD
Fluvoxamine—Loss of consciousness—Epirubicin—prostate cancer	1.37e-05	9.05e-05	CcSEcCtD
Fluvoxamine—Cough—Epirubicin—prostate cancer	1.36e-05	8.98e-05	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—prostate cancer	1.36e-05	8.98e-05	CcSEcCtD
Fluvoxamine—Asthenia—Docetaxel—prostate cancer	1.36e-05	8.94e-05	CcSEcCtD
Fluvoxamine—Convulsion—Epirubicin—prostate cancer	1.35e-05	8.92e-05	CcSEcCtD
Fluvoxamine—Nausea—Etoposide—prostate cancer	1.35e-05	8.9e-05	CcSEcCtD
Fluvoxamine—Hypertension—Epirubicin—prostate cancer	1.35e-05	8.89e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Capecitabine—prostate cancer	1.35e-05	8.89e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Prednisone—prostate cancer	1.34e-05	8.85e-05	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—prostate cancer	1.34e-05	8.84e-05	CcSEcCtD
Fluvoxamine—Pruritus—Docetaxel—prostate cancer	1.34e-05	8.81e-05	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—prostate cancer	1.34e-05	8.81e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Prednisone—prostate cancer	1.33e-05	8.79e-05	CcSEcCtD
Fluvoxamine—Myalgia—Epirubicin—prostate cancer	1.33e-05	8.77e-05	CcSEcCtD
Fluvoxamine—Arthralgia—Epirubicin—prostate cancer	1.33e-05	8.77e-05	CcSEcCtD
Fluvoxamine—Chest pain—Epirubicin—prostate cancer	1.33e-05	8.77e-05	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—prostate cancer	1.33e-05	8.75e-05	CcSEcCtD
Fluvoxamine—Anxiety—Epirubicin—prostate cancer	1.33e-05	8.74e-05	CcSEcCtD
Fluvoxamine—Discomfort—Epirubicin—prostate cancer	1.31e-05	8.66e-05	CcSEcCtD
Fluvoxamine—Asthenia—Capecitabine—prostate cancer	1.31e-05	8.65e-05	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—prostate cancer	1.3e-05	8.59e-05	CcSEcCtD
Fluvoxamine—Dry mouth—Epirubicin—prostate cancer	1.3e-05	8.57e-05	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—prostate cancer	1.3e-05	8.56e-05	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—prostate cancer	1.3e-05	8.54e-05	CcSEcCtD
Fluvoxamine—Urticaria—Prednisone—prostate cancer	1.3e-05	8.54e-05	CcSEcCtD
Fluvoxamine—Pruritus—Capecitabine—prostate cancer	1.3e-05	8.53e-05	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—prostate cancer	1.29e-05	8.53e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Docetaxel—prostate cancer	1.29e-05	8.52e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Prednisone—prostate cancer	1.29e-05	8.49e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Prednisone—prostate cancer	1.29e-05	8.49e-05	CcSEcCtD
Fluvoxamine—Confusional state—Epirubicin—prostate cancer	1.29e-05	8.47e-05	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—prostate cancer	1.28e-05	8.42e-05	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Epirubicin—prostate cancer	1.28e-05	8.4e-05	CcSEcCtD
Fluvoxamine—Oedema—Epirubicin—prostate cancer	1.28e-05	8.4e-05	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—prostate cancer	1.27e-05	8.37e-05	CcSEcCtD
Fluvoxamine—Infection—Epirubicin—prostate cancer	1.27e-05	8.35e-05	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—prostate cancer	1.26e-05	8.31e-05	CcSEcCtD
Fluvoxamine—Shock—Epirubicin—prostate cancer	1.26e-05	8.27e-05	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—prostate cancer	1.25e-05	8.25e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Capecitabine—prostate cancer	1.25e-05	8.25e-05	CcSEcCtD
Fluvoxamine—Nervous system disorder—Epirubicin—prostate cancer	1.25e-05	8.24e-05	CcSEcCtD
Fluvoxamine—Dizziness—Docetaxel—prostate cancer	1.25e-05	8.24e-05	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Epirubicin—prostate cancer	1.25e-05	8.23e-05	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—prostate cancer	1.25e-05	8.23e-05	CcSEcCtD
Fluvoxamine—Tachycardia—Epirubicin—prostate cancer	1.25e-05	8.2e-05	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Epirubicin—prostate cancer	1.23e-05	8.12e-05	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—prostate cancer	1.23e-05	8.11e-05	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—prostate cancer	1.23e-05	8.11e-05	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—prostate cancer	1.23e-05	8.11e-05	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—prostate cancer	1.23e-05	8.08e-05	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—prostate cancer	1.22e-05	8.01e-05	CcSEcCtD
Fluvoxamine—Anorexia—Epirubicin—prostate cancer	1.22e-05	8.01e-05	CcSEcCtD
Fluvoxamine—Dizziness—Capecitabine—prostate cancer	1.21e-05	7.98e-05	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—prostate cancer	1.2e-05	7.93e-05	CcSEcCtD
Fluvoxamine—Vomiting—Docetaxel—prostate cancer	1.2e-05	7.92e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Prednisone—prostate cancer	1.2e-05	7.92e-05	CcSEcCtD
Fluvoxamine—Rash—Docetaxel—prostate cancer	1.19e-05	7.86e-05	CcSEcCtD
Fluvoxamine—Hypotension—Epirubicin—prostate cancer	1.19e-05	7.85e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Docetaxel—prostate cancer	1.19e-05	7.85e-05	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—prostate cancer	1.19e-05	7.84e-05	CcSEcCtD
Fluvoxamine—Headache—Docetaxel—prostate cancer	1.18e-05	7.8e-05	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—prostate cancer	1.18e-05	7.78e-05	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—prostate cancer	1.18e-05	7.78e-05	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—prostate cancer	1.17e-05	7.72e-05	CcSEcCtD
Fluvoxamine—Asthenia—Prednisone—prostate cancer	1.17e-05	7.71e-05	CcSEcCtD
Fluvoxamine—Vomiting—Capecitabine—prostate cancer	1.16e-05	7.67e-05	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.16e-05	7.66e-05	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—prostate cancer	1.16e-05	7.65e-05	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—prostate cancer	1.16e-05	7.62e-05	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—prostate cancer	1.16e-05	7.61e-05	CcSEcCtD
Fluvoxamine—Rash—Capecitabine—prostate cancer	1.15e-05	7.61e-05	CcSEcCtD
Fluvoxamine—Pruritus—Prednisone—prostate cancer	1.15e-05	7.6e-05	CcSEcCtD
Fluvoxamine—Insomnia—Epirubicin—prostate cancer	1.15e-05	7.6e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Capecitabine—prostate cancer	1.15e-05	7.6e-05	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—prostate cancer	1.15e-05	7.59e-05	CcSEcCtD
Fluvoxamine—Headache—Capecitabine—prostate cancer	1.15e-05	7.56e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Epirubicin—prostate cancer	1.15e-05	7.55e-05	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Doxorubicin—prostate cancer	1.14e-05	7.52e-05	CcSEcCtD
Fluvoxamine—Dyspnoea—Epirubicin—prostate cancer	1.14e-05	7.49e-05	CcSEcCtD
Fluvoxamine—Somnolence—Epirubicin—prostate cancer	1.13e-05	7.47e-05	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—prostate cancer	1.13e-05	7.41e-05	CcSEcCtD
Fluvoxamine—Nausea—Docetaxel—prostate cancer	1.12e-05	7.4e-05	CcSEcCtD
Fluvoxamine—Dyspepsia—Epirubicin—prostate cancer	1.12e-05	7.4e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Prednisone—prostate cancer	1.12e-05	7.35e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Epirubicin—prostate cancer	1.11e-05	7.3e-05	CcSEcCtD
Fluvoxamine—Hypotension—Doxorubicin—prostate cancer	1.1e-05	7.27e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.1e-05	7.25e-05	CcSEcCtD
Fluvoxamine—Fatigue—Epirubicin—prostate cancer	1.1e-05	7.24e-05	CcSEcCtD
Fluvoxamine—Constipation—Epirubicin—prostate cancer	1.09e-05	7.19e-05	CcSEcCtD
Fluvoxamine—Pain—Epirubicin—prostate cancer	1.09e-05	7.19e-05	CcSEcCtD
Fluvoxamine—Nausea—Capecitabine—prostate cancer	1.09e-05	7.16e-05	CcSEcCtD
Fluvoxamine—Dizziness—Prednisone—prostate cancer	1.08e-05	7.1e-05	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.08e-05	7.08e-05	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—prostate cancer	1.07e-05	7.03e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—prostate cancer	1.06e-05	6.98e-05	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—prostate cancer	1.05e-05	6.93e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Epirubicin—prostate cancer	1.05e-05	6.92e-05	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—prostate cancer	1.05e-05	6.91e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Epirubicin—prostate cancer	1.04e-05	6.87e-05	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—prostate cancer	1.04e-05	6.84e-05	CcSEcCtD
Fluvoxamine—Vomiting—Prednisone—prostate cancer	1.04e-05	6.83e-05	CcSEcCtD
Fluvoxamine—Rash—Prednisone—prostate cancer	1.03e-05	6.77e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Prednisone—prostate cancer	1.03e-05	6.77e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—prostate cancer	1.03e-05	6.76e-05	CcSEcCtD
Fluvoxamine—Headache—Prednisone—prostate cancer	1.02e-05	6.73e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.02e-05	6.71e-05	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—prostate cancer	1.02e-05	6.7e-05	CcSEcCtD
Fluvoxamine—Urticaria—Epirubicin—prostate cancer	1.01e-05	6.68e-05	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—prostate cancer	1.01e-05	6.65e-05	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—prostate cancer	1.01e-05	6.65e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Epirubicin—prostate cancer	1.01e-05	6.64e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Epirubicin—prostate cancer	1.01e-05	6.64e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Doxorubicin—prostate cancer	9.73e-06	6.41e-05	CcSEcCtD
Fluvoxamine—Nausea—Prednisone—prostate cancer	9.69e-06	6.38e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—prostate cancer	9.65e-06	6.36e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Epirubicin—prostate cancer	9.4e-06	6.19e-05	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—prostate cancer	9.38e-06	6.18e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—prostate cancer	9.33e-06	6.15e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Doxorubicin—prostate cancer	9.33e-06	6.15e-05	CcSEcCtD
Fluvoxamine—Asthenia—Epirubicin—prostate cancer	9.15e-06	6.03e-05	CcSEcCtD
Fluvoxamine—Pruritus—Epirubicin—prostate cancer	9.03e-06	5.95e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Epirubicin—prostate cancer	8.73e-06	5.75e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—prostate cancer	8.7e-06	5.73e-05	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—prostate cancer	8.47e-06	5.58e-05	CcSEcCtD
Fluvoxamine—Dizziness—Epirubicin—prostate cancer	8.44e-06	5.56e-05	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—prostate cancer	8.35e-06	5.5e-05	CcSEcCtD
Fluvoxamine—Vomiting—Epirubicin—prostate cancer	8.11e-06	5.34e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—prostate cancer	8.08e-06	5.32e-05	CcSEcCtD
Fluvoxamine—Rash—Epirubicin—prostate cancer	8.04e-06	5.3e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Epirubicin—prostate cancer	8.04e-06	5.29e-05	CcSEcCtD
Fluvoxamine—Headache—Epirubicin—prostate cancer	7.99e-06	5.26e-05	CcSEcCtD
Fluvoxamine—Dizziness—Doxorubicin—prostate cancer	7.81e-06	5.14e-05	CcSEcCtD
Fluvoxamine—Nausea—Epirubicin—prostate cancer	7.58e-06	4.99e-05	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—prostate cancer	7.51e-06	4.94e-05	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—prostate cancer	7.44e-06	4.9e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—prostate cancer	7.44e-06	4.9e-05	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—prostate cancer	7.4e-06	4.87e-05	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—prostate cancer	7.01e-06	4.62e-05	CcSEcCtD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—prostate cancer	1.7e-06	1.92e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.7e-06	1.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.7e-06	1.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—RXRA—prostate cancer	1.69e-06	1.91e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARA—prostate cancer	1.67e-06	1.89e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARA—prostate cancer	1.67e-06	1.89e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GGT1—prostate cancer	1.66e-06	1.88e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.66e-06	1.87e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—RXRA—prostate cancer	1.65e-06	1.86e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GGT1—prostate cancer	1.65e-06	1.86e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.64e-06	1.86e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NCOA2—prostate cancer	1.64e-06	1.86e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NOS3—prostate cancer	1.64e-06	1.86e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NCOA1—prostate cancer	1.64e-06	1.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—COMT—prostate cancer	1.63e-06	1.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTP1—prostate cancer	1.62e-06	1.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NCOA1—prostate cancer	1.62e-06	1.83e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.62e-06	1.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.61e-06	1.82e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—prostate cancer	1.61e-06	1.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CAV1—prostate cancer	1.61e-06	1.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.6e-06	1.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ITPR1—prostate cancer	1.6e-06	1.8e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MED12—prostate cancer	1.59e-06	1.8e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—COMT—prostate cancer	1.59e-06	1.8e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTP1—prostate cancer	1.58e-06	1.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARA—prostate cancer	1.58e-06	1.78e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GNG5—prostate cancer	1.58e-06	1.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CAV1—prostate cancer	1.57e-06	1.78e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CAV1—prostate cancer	1.57e-06	1.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.57e-06	1.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.57e-06	1.77e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ITPR1—prostate cancer	1.56e-06	1.76e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—RXRA—prostate cancer	1.56e-06	1.76e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—RXRA—prostate cancer	1.54e-06	1.74e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.53e-06	1.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NCOA3—prostate cancer	1.52e-06	1.72e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CB—prostate cancer	1.52e-06	1.71e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NQO1—prostate cancer	1.51e-06	1.71e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TYMS—prostate cancer	1.51e-06	1.7e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—prostate cancer	1.5e-06	1.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.5e-06	1.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—COMT—prostate cancer	1.5e-06	1.69e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TH—prostate cancer	1.49e-06	1.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTP1—prostate cancer	1.49e-06	1.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—prostate cancer	1.49e-06	1.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—COMT—prostate cancer	1.49e-06	1.68e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CAV1—prostate cancer	1.48e-06	1.68e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.48e-06	1.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTP1—prostate cancer	1.48e-06	1.67e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.48e-06	1.67e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TYMS—prostate cancer	1.47e-06	1.66e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.47e-06	1.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ITPR1—prostate cancer	1.47e-06	1.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CG—prostate cancer	1.46e-06	1.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—LPL—prostate cancer	1.46e-06	1.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ITPR1—prostate cancer	1.45e-06	1.64e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—prostate cancer	1.45e-06	1.64e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.45e-06	1.64e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.45e-06	1.64e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.44e-06	1.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.43e-06	1.62e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.43e-06	1.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.43e-06	1.62e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—LPL—prostate cancer	1.43e-06	1.61e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.42e-06	1.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ACHE—prostate cancer	1.41e-06	1.59e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.41e-06	1.59e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GGT1—prostate cancer	1.41e-06	1.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ERCC2—prostate cancer	1.4e-06	1.58e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.39e-06	1.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TYMS—prostate cancer	1.39e-06	1.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—INS—prostate cancer	1.39e-06	1.57e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NCOA1—prostate cancer	1.39e-06	1.57e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP1A1—prostate cancer	1.38e-06	1.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TYMS—prostate cancer	1.37e-06	1.55e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.37e-06	1.55e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ERCC2—prostate cancer	1.37e-06	1.54e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.37e-06	1.54e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—prostate cancer	1.36e-06	1.53e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CREBBP—prostate cancer	1.36e-06	1.53e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—INS—prostate cancer	1.36e-06	1.53e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—INS—prostate cancer	1.35e-06	1.53e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.35e-06	1.53e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CG—prostate cancer	1.35e-06	1.53e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.35e-06	1.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—LPL—prostate cancer	1.35e-06	1.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—LPL—prostate cancer	1.33e-06	1.51e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.33e-06	1.5e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CREBBP—prostate cancer	1.33e-06	1.5e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CREBBP—prostate cancer	1.33e-06	1.5e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—RXRA—prostate cancer	1.32e-06	1.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—prostate cancer	1.32e-06	1.49e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTEN—prostate cancer	1.31e-06	1.48e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.3e-06	1.47e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARA—prostate cancer	1.29e-06	1.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.29e-06	1.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.29e-06	1.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.29e-06	1.45e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—prostate cancer	1.29e-06	1.45e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—INS—prostate cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ERCC2—prostate cancer	1.28e-06	1.44e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—COMT—prostate cancer	1.27e-06	1.43e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.27e-06	1.43e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTP1—prostate cancer	1.26e-06	1.43e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARA—prostate cancer	1.26e-06	1.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.26e-06	1.42e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.26e-06	1.42e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CREBBP—prostate cancer	1.25e-06	1.42e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—EP300—prostate cancer	1.25e-06	1.41e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.24e-06	1.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.22e-06	1.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NOS3—prostate cancer	1.22e-06	1.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAV1—prostate cancer	1.21e-06	1.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.21e-06	1.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.21e-06	1.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—prostate cancer	1.2e-06	1.36e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NOS3—prostate cancer	1.19e-06	1.34e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CD—prostate cancer	1.19e-06	1.34e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARA—prostate cancer	1.19e-06	1.34e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NOS3—prostate cancer	1.19e-06	1.34e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAV1—prostate cancer	1.19e-06	1.34e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.18e-06	1.34e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARA—prostate cancer	1.18e-06	1.33e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TYMS—prostate cancer	1.17e-06	1.33e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NQO1—prostate cancer	1.17e-06	1.32e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.16e-06	1.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.16e-06	1.31e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TH—prostate cancer	1.15e-06	1.3e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—LPL—prostate cancer	1.14e-06	1.29e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NOS3—prostate cancer	1.12e-06	1.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.12e-06	1.27e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.12e-06	1.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAV1—prostate cancer	1.12e-06	1.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—prostate cancer	1.11e-06	1.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAV1—prostate cancer	1.11e-06	1.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.11e-06	1.25e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.1e-06	1.24e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.1e-06	1.24e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.1e-06	1.24e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.09e-06	1.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—prostate cancer	1.09e-06	1.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—prostate cancer	1.09e-06	1.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GGT1—prostate cancer	1.09e-06	1.23e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CG—prostate cancer	1.08e-06	1.22e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.07e-06	1.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.06e-06	1.2e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.05e-06	1.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—INS—prostate cancer	1.05e-06	1.18e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CB—prostate cancer	1.04e-06	1.17e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—prostate cancer	1.03e-06	1.16e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.03e-06	1.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.03e-06	1.16e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—INS—prostate cancer	1.02e-06	1.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.02e-06	1.15e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—RXRA—prostate cancer	1.02e-06	1.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.01e-06	1.14e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARA—prostate cancer	1.01e-06	1.14e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CREBBP—prostate cancer	1e-06	1.13e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—COMT—prostate cancer	9.8e-07	1.11e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTP1—prostate cancer	9.75e-07	1.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CD—prostate cancer	9.73e-07	1.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTEN—prostate cancer	9.69e-07	1.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—INS—prostate cancer	9.63e-07	1.09e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ITPR1—prostate cancer	9.59e-07	1.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—INS—prostate cancer	9.55e-07	1.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTEN—prostate cancer	9.5e-07	1.07e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CD—prostate cancer	9.49e-07	1.07e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTEN—prostate cancer	9.48e-07	1.07e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAV1—prostate cancer	9.46e-07	1.07e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CREBBP—prostate cancer	9.44e-07	1.07e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CREBBP—prostate cancer	9.35e-07	1.06e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—prostate cancer	9.25e-07	1.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—EP300—prostate cancer	9.25e-07	1.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NOS3—prostate cancer	9.18e-07	1.04e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TYMS—prostate cancer	9.06e-07	1.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—EP300—prostate cancer	9.06e-07	1.02e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.04e-07	1.02e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—EP300—prostate cancer	9.04e-07	1.02e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NOS3—prostate cancer	8.96e-07	1.01e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—prostate cancer	8.96e-07	1.01e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTEN—prostate cancer	8.95e-07	1.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CD—prostate cancer	8.95e-07	1.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CD—prostate cancer	8.87e-07	1e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LPL—prostate cancer	8.8e-07	9.94e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CG—prostate cancer	8.62e-07	9.74e-06	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—EP300—prostate cancer	8.54e-07	9.65e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1A1—prostate cancer	8.49e-07	9.6e-06	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CB—prostate cancer	8.48e-07	9.58e-06	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NOS3—prostate cancer	8.45e-07	9.54e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ERCC2—prostate cancer	8.42e-07	9.52e-06	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—prostate cancer	8.4e-07	9.49e-06	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NOS3—prostate cancer	8.37e-07	9.46e-06	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CB—prostate cancer	8.27e-07	9.35e-06	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—prostate cancer	8.2e-07	9.26e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—INS—prostate cancer	8.16e-07	9.22e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CREBBP—prostate cancer	7.99e-07	9.03e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—prostate cancer	7.92e-07	8.95e-06	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CB—prostate cancer	7.8e-07	8.81e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARA—prostate cancer	7.77e-07	8.78e-06	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CB—prostate cancer	7.73e-07	8.73e-06	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—prostate cancer	7.73e-07	8.73e-06	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—prostate cancer	7.66e-07	8.65e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CD—prostate cancer	7.58e-07	8.56e-06	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—prostate cancer	7.55e-07	8.53e-06	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTEN—prostate cancer	7.33e-07	8.28e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAV1—prostate cancer	7.3e-07	8.25e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NOS3—prostate cancer	7.16e-07	8.08e-06	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTEN—prostate cancer	7.15e-07	8.08e-06	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—EP300—prostate cancer	6.99e-07	7.89e-06	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—prostate cancer	6.84e-07	7.73e-06	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—EP300—prostate cancer	6.82e-07	7.7e-06	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTEN—prostate cancer	6.74e-07	7.61e-06	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—prostate cancer	6.7e-07	7.57e-06	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—prostate cancer	6.68e-07	7.55e-06	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTEN—prostate cancer	6.68e-07	7.55e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CG—prostate cancer	6.65e-07	7.52e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CB—prostate cancer	6.61e-07	7.46e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—prostate cancer	6.55e-07	7.39e-06	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—EP300—prostate cancer	6.43e-07	7.26e-06	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—EP300—prostate cancer	6.37e-07	7.2e-06	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—prostate cancer	6.32e-07	7.13e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—INS—prostate cancer	6.3e-07	7.12e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CREBBP—prostate cancer	6.17e-07	6.97e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CD—prostate cancer	5.85e-07	6.61e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTEN—prostate cancer	5.71e-07	6.45e-06	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—prostate cancer	5.59e-07	6.31e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NOS3—prostate cancer	5.52e-07	6.24e-06	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—prostate cancer	5.47e-07	6.18e-06	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—prostate cancer	5.46e-07	6.17e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—EP300—prostate cancer	5.44e-07	6.15e-06	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—prostate cancer	5.17e-07	5.84e-06	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—prostate cancer	5.16e-07	5.83e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.1e-07	5.76e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—prostate cancer	5.05e-07	5.71e-06	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—prostate cancer	5.04e-07	5.7e-06	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.75e-07	5.37e-06	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—prostate cancer	4.71e-07	5.32e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTEN—prostate cancer	4.41e-07	4.98e-06	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—prostate cancer	4.22e-07	4.77e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—EP300—prostate cancer	4.2e-07	4.75e-06	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—prostate cancer	4.12e-07	4.66e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—prostate cancer	4.03e-07	4.55e-06	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—prostate cancer	3.88e-07	4.39e-06	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—prostate cancer	3.85e-07	4.35e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—prostate cancer	3.29e-07	3.72e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.11e-07	3.51e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—prostate cancer	2.54e-07	2.87e-06	CbGpPWpGaD
